Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04786184 · ClinicalTrials.gov registry record · NA

Capnography-Assisted Learned Monitored (CALM) Breathing Therapy for COPD

A NA study of COPD, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
42
Enrollment target
2
Study locations

NCT04786184 is a NA study of COPD that has completed, run by Columbia University. The registered enrollment target is 42 participants, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04786184, a NA study of COPD, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target
2
Study locations

Study Summary

This pilot study is part of a phased approach to refine, optimize, and test the feasibility of CALM Breathing. Preliminary participant feedback from the Capnography-Assisted Respiratory Therapy (CART) study was applied to adapt and design CALM Breathing (including its dose, schedule, delivery, and home program). This pilot builds on initial lessons learned and identifies intervention areas still needing greater development to assure the success of a future large trial, targeting a subpopulation at risk, that is, those with COPD and anxiety sensitivity.

Conditions Studied

Interventions

  • BEHAVIORAL CALM Breathing
  • BEHAVIORAL Traditional outpatient PR

Study Locations (2)

New York

  • New York University Grossman School of Medicine - New York
  • Columbia University Irving Medical Center - New York

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2021-10-01
Est. Completion 2023-11-30
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT04786184

The ClinicalTrials.gov registry entry for NCT04786184 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (98% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COPD appearing as the primary indexed condition, and to 2 interventions - of which CALM Breathing is the first listed.

NCT04786184 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04786184 about?

NCT04786184 is a clinical study titled "Capnography-Assisted Learned Monitored (CALM) Breathing Therapy for COPD". This pilot study is part of a phased approach to refine, optimize, and test the feasibility of CALM Breathing. Preliminary participant feedback from the Capnography-Assisted Respiratory Therapy (CART) study was applied to adapt and design CALM Breathing (including its dose, schedule, delivery, and h...

What is the current status of trial NCT04786184?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2021-10-01. Estimated completion is 2023-11-30.

What conditions does trial NCT04786184 study?

This clinical trial studies the following conditions: COPD.

What interventions are being tested in trial NCT04786184?

The interventions under investigation include: CALM Breathing (BEHAVIORAL), Traditional outpatient PR (BEHAVIORAL).

Who is sponsoring clinical trial NCT04786184?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04786184 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.